News OpenAI Foundation pledges $100m to boost hepatitis C cure ra... The OpenAI Foundation has committed $100m to help fund a new public health initiative initially focused on hepatitis C.
Oncology Radiopharma in 2026 & beyond, with ITM's Dr Andrew Cavey Dr Andrew Cavey, CEO of ITM, discusses current and future radiopharmaceutical trends.
Oncology How can an engineering background change the approach to dev... Sometimes all it takes to make a breakthrough in research, in any field, is to look at the problem differently than anybody has before.
Oncology Life Sciences Industry Report - Oncology Developments in the oncology space in 2024 brought hope to both industry and patients.
Oncology ESMO 2024 - Sven Schaffer The European Society for Medical Oncology (ESMO) 2024 meeting was a well-attended affair at the sprawling Fira Gran Via centre in Barcelona.
Oncology Chimeric antigen receptor T-cells: Emerging uses and future ... Genetic engineering technologies allow for the creation of custom-made cells that can have transformative effects on human health.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
